Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 4 TO FORM S-1 - Vyant Bio, Inc. | d254016ds1a.htm |
| EX-5.1 - OPINION OF LOWENSTEIN SANDLER PC - Vyant Bio, Inc. | d254016dex51.htm |
| EX-1.1 - FORM OF UNDERWRITING AGREEMENT - Vyant Bio, Inc. | d254016dex11.htm |
| EX-10.42 - FUNDING COMMITMENT LETTER - Vyant Bio, Inc. | d254016dex1042.htm |
| EX-10.44 - LETTER AGREEMENT BETWEEN MEADOWS OFFICE, L.L.C. AND CANCER GENETICS, INC. - Vyant Bio, Inc. | d254016dex1044.htm |
| EX-10.20 - OFFICE LEASE AGREEMENT - Vyant Bio, Inc. | d254016dex1020.htm |
| EX-10.43 - LETTER AGREEMENT BETWEEN PANNA SHARMA AND CANCER GENETICS, INC. - Vyant Bio, Inc. | d254016dex1043.htm |
| EX-10.45 - LETTER AGREEMENT BETWEEN MEADOWS OFFICE, L.L.C. AND CANCER GENETICS, INC. - Vyant Bio, Inc. | d254016dex1045.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 4 to the Registration Statement (No. 333-178836) on Form S-1 of Cancer Genetics, Inc. and subsidiary of our report dated March 13, 2012, relating to our audits of the consolidated financial statements, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
| /s/ McGladrey & Pullen, LLP |
| Des Moines, Iowa |
| April 23, 2012 |